Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Jul 28, 2006; 12(28): 4452-4460
Published online Jul 28, 2006. doi: 10.3748/wjg.v12.i28.4452
Published online Jul 28, 2006. doi: 10.3748/wjg.v12.i28.4452
Bacterial counts (mean ± SD) | Positive rate (%) | ||||
UC | Control | UC | Control | ||
Total | 6.63 ± 0.96 | 5.47 ± 0.96 | |||
Aerobes | 6.23 ± 0.50 | 5.28 ± 2.47 | |||
Anaerobes | 6.42 ± 1.05 | 5.01 ± 0.76 | |||
Clostridium | 4.64 ± 2.07 | 3.74 ± 2.02 | 61.1 | 42.9 | |
Bacteroides | 5.33 ± 1.71 | 3.96 ± 1.66 | 94.4 | 85.7 | |
Bifidobacterium | 5.32 ± 2.64 | 4.25 ± 2.24 | 44.4 | 28.6 | |
Eubacterium | 4.73 ± 2.13 | 2.73 ± 1.53 | 33.3 | 57.1 | |
Fusobacterium | 0 | 4.14 ± 1.95 | 0 | 28.6 | |
Actinomyces | 2.28 ± 0.83 | 0 | 5.5 | 0 | |
Veillonella | 4.82 ± 1.79 | 0 | 11.1 | 0 | |
Peptostreptococcus | 4.53 ± 2.17 | 1.80 ± 1.14 | 38.8 | 28.6 | |
Streptococcus | 4.93 ± 2.33 | 3.03 ± 1.47 | 27.7 | 14.3 | |
Peptococcu | 3.35 ± 1.34 | 0 | 11.1 | 0 |
- Citation: Andoh A, Fujiyama Y. Therapeutic approaches targeting intestinal microflora in inflammatory bowel disease. World J Gastroenterol 2006; 12(28): 4452-4460
- URL: https://www.wjgnet.com/1007-9327/full/v12/i28/4452.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i28.4452